| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| NEKTAR THERAPEUTICS | SVP & Chief Commercial Officer | Common Stock | 223,210 | $109,373 | $0.4900 | 16 May 2022 | Direct |
| NEKTAR THERAPEUTICS | SVP & Chief Commercial Officer | Stock Option | 67,150 | 16 Dec 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| NKTR | NEKTAR THERAPEUTICS | 16 May 2022 | 1 | -$18,138 | 4 | SVP & Chief Commercial Officer | 17 May 2022, 21:33 |
| NKTR | NEKTAR THERAPEUTICS | 16 Feb 2022 | 1 | -$53,129 | 4 | SVP & Chief Commercial Officer | 18 Feb 2022, 17:15 |
| NKTR | NEKTAR THERAPEUTICS | 16 Dec 2021 | 2 | $0 | 4 | SVP & Chief Commercial Officer | 20 Dec 2021, 19:24 |
| NKTR | NEKTAR THERAPEUTICS | 16 Nov 2021 | 1 | -$79,763 | 4 | SVP & Chief Commercial Officer | 17 Nov 2021, 17:06 |
| NKTR | NEKTAR THERAPEUTICS | 16 Aug 2021 | 1 | -$85,635 | 4 | SVP & Chief Commercial Officer | 18 Aug 2021, 18:59 |
| NKTR | NEKTAR THERAPEUTICS | 17 May 2021 | 1 | -$111,356 | 4 | SVP & Chief Commercial Officer | 19 May 2021, 19:04 |